Navigation Links
Drug-embedded microparticles bolster heart function in animal studies
Date:10/19/2008

Researchers at Emory University and Georgia Institute of Technology have developed tiny polymer beads that can slowly release anti-inflammatory drugs and break down into non-toxic components.

When injected into rats' hearts after a simulated heart attack, the drug-embedded "microparticles" reduce inflammation and scarring, the researchers found. Injecting the particles could cut the area of scar tissue formed after the heart attack in half and boost the ability of the heart to pump blood by 10 percent weeks later.

The results are published online this week and are scheduled for publication in the Oct/Nov issue of Nature Materials.

Doctors believe that certain anti-inflammatory drugs, if delivered directly into the heart after a heart attack, could prevent permanent damage and reduce the probability of heart failure later in life.

Fulfilling this idea -- getting drugs to the right place at the right time -- is more challenging than simply swallowing an aspirin, says senior author Michael Davis, PhD, assistant professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.

"If you look at previous studies to see what it would take to get enough of these drugs into the heart, they did things like direct injections twice a day," he says. "And there are clear toxicity issues if the whole body is exposed to the drug."

As an alternative, Davis and graduate student Jay Sy, the first author of the paper, turned to microscopic particles made of a material called polyketals, developed by co-author Niren Murthy, PhD, assistant professor of biomedical engineering.

The microparticles break down over a few weeks in the body, releasing the experimental drug SB239063. This drug inhibits an enzyme, MAP kinase, which is important during the damaging inflammation that occurs after a heart attack.

Davis says the drug gradually leaches out of the polyketal particles half is gone after a week of just sitting around in warm water. In addition, the microparticles are broken down by white blood cells called macrophages.

"These are actually cells we're trying to reach with the drug, because they're involved in the inflammatory response in the heart," he says. "The macrophages can surround and eat the particles, or fuse together if the particles are too big."

Davis says polyketals have an advantage over other biodegradable polymers, in that they break down into neutral, excretable compounds that aren't themselves inflammatory.

Polyesters such as PLGA (polylactic-co-glycolic acid) are approved for use in sutures and grafts. However, when they are made into particles small enough to be broken down in the body, polyesters cause inflammation exactly what the drugs are supposed to stop, he says.

When the particles were injected into rats' hearts, the researchers could see an inhibition of the MAP kinase enzyme lasting for a week. However, the effect on heart function was greater after 21 days. Davis says this result suggests that the main way the particles helped the heart was to prevent the scarring that sets in after the initial tissue damage of a heart attack.

He and Murthy are exploring polyketal particles as delivery vehicles for drugs or proteins in several organs: heart, liver, lungs and spinal cord.


'/>"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University
Source:Eurekalert

Related biology news :

1. Broad Institute awarded major grant to bolster epigenomics research
2. Argonne-University of Chicago joint venture bolsters genomic sequencing capabilities
3. Student study bolsters case for adding a rare sunflower to the endangered species list
4. Student study bolsters case for adding a rare sunflower to the endangered species list
5. Repair in the developing heart
6. Embryonic heart exhibits impressive regenerative capacity
7. Study provides insight on a common heart rhythm disorder
8. LIAI launches new division to look at novel approaches to heart disease and inflammation
9. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
10. Researchers study how pistachios may improve heart health
11. NIH awards Clemson bioengineer $1.5 million to improve durability of tissue heart valves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... 2017  Wake Forest Baptist Medical Center today announced Julie ... executive officer (CEO). Freischlag joins the medical center on ... , M.D., who last year announced that he would ... after leading it since 2008.   As ... Forest Baptist,s academic health system, which includes Wake Forest ...
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
(Date:2/9/2017)... , Feb. 9, 2017 The biomass boiler ... of the biomass boiler market globally in terms of ... biomass boilers. The market for biomass boilers has been ... end-user, application, and country/region. The market based on feedstock ... forest residues, biogas & energy crops, urban residues, and ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... March 29, 2017 QIAGEN N.V. (NASDAQ: QGEN ... the U.S. launch of its ipsogen ® JAK2 RGQ PCR ... and Drug Administration as a qualitative in vitro diagnostic test for the detection ... ... processed on QIAGEN,s Rotor-Gene ® Q MDx system, which is a member ...
(Date:3/29/2017)... ... March 29, 2017 , ... (March 29, 2017) ... has been approved as an active member of the Mexican Direct Selling ... distributers and consumers in relationship marketing. This professional organization fosters loyal and fair ...
(Date:3/29/2017)... ... 29, 2017 , ... ACEA Biosciences, a privately owned biotechnology ... award to noteworthy scientists who will be presenting research using ACEA Biosciences’ technology ... awards are being given to two postdoctoral fellows studying pathogen capture by neutrophils, ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - The University ... partners Nordion, a business of Sterigenics International, and General ... has been submitted to the U.S. Nuclear Regulatory Commission ... U.S. production of molybdenum-99 (Mo-99). Once operational, production from ... of U.S. demand for Mo-99, which currently must be ...
Breaking Biology Technology: